Company AroCell AB (publ) Nasdaq Stockholm

Equities

SE0003883990

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

AroCell publ AB is a Sweden-based diagnostic Company engaged in the development of markers for determination of cell growth (TK 210) and apoptosis. The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. The test is based on a patented technology, which have already been evaluated in an early product prototype ELISA method. Apart from that, the Company develops a marker for solid tumor cancer disease. The AroCell cooperates with partners within development, production and sales.

SEK in Million	2020	Weight	2021	Weight	Delta
Research and Development in Cell Biology and Medicine 100.0 %	0	100.0 %	12	100.0 %	+14,180.95%

SEK in Million	2020	Weight	2021	Weight	Delta
Sweden 100.0 %	0	100.0 %	12	100.0 %	+14,180.95%

Managers	Title	Age	Since
Anders Hultman CEO	Chief Executive Officer	50	01/18/01
Lars Jakobsson DFI	Director of Finance/CFO	67	-
Gustav Sten COO	Chief Operating Officer	-	01/19/01
Gunnar Steineck CTO	Chief Tech/Sci/R&D Officer	-	01/17/01
Kiran Kumar Jagarlamudi CTO	Chief Tech/Sci/R&D Officer	-	01/15/01
Alona Nyberg IRC	Investor Relations Contact	-	01/19/01
Gunnar Wahlberg SAM	Sales & Marketing	54	01/21/01
Tina Yang PRN	Corporate Officer/Principal	-	01/17/01
Peter Lowendahl LAW	General Counsel	-	01/19/01
Filip Fogdestam PRN	Corporate Officer/Principal	-	01/14/01

Members of the board	Title	Age	Since
Johan Erik Häggblad CHM	Chairman	65	01/22/01
Charlotta Ljungqvist BRD	Director/Board Member	63	01/21/01
Clas Runnberg BRD	Director/Board Member	72	01/23/01
Gunnar Steineck CTO	Chief Tech/Sci/R&D Officer	-	01/17/01
Max Pihlqvist BRD	Director/Board Member	37	01/22/01
Eva Nordström BRD	Director/Board Member	54	01/20/01
Agneta Tufvesson Alm BRD	Director/Board Member	-	01/22/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	230,361,066	102,183,486 ( 44.36 %)	0	44.36 %

Name	Equities	%	Valuation
Arvernus Capital AG 0.1912 %	440,492	0.1912 %	15 162 kr

AroCell AB

Karlsbodavägen 39

168 67, Bromma Stockholm

+46 87 99 67 50

http://www.arocell.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+23.37%	46.71B
LONZA GROUP AG	+48.83%	41.8B
IQVIA HOLDINGS INC.	-0.94%	41.52B
CELLTRION, INC.	-5.86%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.29%	25.78B
ALNYLAM PHARMACEUTICALS, INC.	-20.92%	19.26B
BIO-TECHNE CORPORATION	+3.20%	12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-2.67%	12.08B
MEDPACE HOLDINGS, INC.	+30.23%	11.98B

Other Biotechnology & Medical Research